149 related articles for article (PubMed ID: 34298241)
1. Discovery of novel inhibitors of human phosphoglycerate dehydrogenase by activity-directed combinatorial chemical synthesis strategy.
Zhou X; Tan Y; Gou K; Tao L; Luo Y; Zhou Y; Zuo Z; Sun Q; Luo Y; Zhao Y
Bioorg Chem; 2021 Oct; 115():105159. PubMed ID: 34298241
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells.
Mullarky E; Xu J; Robin AD; Huggins DJ; Jennings A; Noguchi N; Olland A; Lakshminarasimhan D; Miller M; Tomita D; Michino M; Su T; Zhang G; Stamford AW; Meinke PT; Kargman S; Cantley LC
Bioorg Med Chem Lett; 2019 Sep; 29(17):2503-2510. PubMed ID: 31327531
[TBL] [Abstract][Full Text] [Related]
3. A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate.
Pacold ME; Brimacombe KR; Chan SH; Rohde JM; Lewis CA; Swier LJ; Possemato R; Chen WW; Sullivan LB; Fiske BP; Cho S; Freinkman E; Birsoy K; Abu-Remaileh M; Shaul YD; Liu CM; Zhou M; Koh MJ; Chung H; Davidson SM; Luengo A; Wang AQ; Xu X; Yasgar A; Liu L; Rai G; Westover KD; Vander Heiden MG; Shen M; Gray NS; Boxer MB; Sabatini DM
Nat Chem Biol; 2016 Jun; 12(6):452-8. PubMed ID: 27110680
[TBL] [Abstract][Full Text] [Related]
4. Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers.
Mullarky E; Lucki NC; Beheshti Zavareh R; Anglin JL; Gomes AP; Nicolay BN; Wong JC; Christen S; Takahashi H; Singh PK; Blenis J; Warren JD; Fendt SM; Asara JM; DeNicola GM; Lyssiotis CA; Lairson LL; Cantley LC
Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1778-83. PubMed ID: 26831078
[TBL] [Abstract][Full Text] [Related]
5. Rational Design of Selective Allosteric Inhibitors of PHGDH and Serine Synthesis with Anti-tumor Activity.
Wang Q; Liberti MV; Liu P; Deng X; Liu Y; Locasale JW; Lai L
Cell Chem Biol; 2017 Jan; 24(1):55-65. PubMed ID: 28042046
[TBL] [Abstract][Full Text] [Related]
6. Intracellular Trapping of the Selective Phosphoglycerate Dehydrogenase (PHGDH) Inhibitor
Weinstabl H; Treu M; Rinnenthal J; Zahn SK; Ettmayer P; Bader G; Dahmann G; Kessler D; Rumpel K; Mischerikow N; Savarese F; Gerstberger T; Mayer M; Zoephel A; Schnitzer R; Sommergruber W; Martinelli P; Arnhof H; Peric-Simov B; Hofbauer KS; Garavel G; Scherbantin Y; Mitzner S; Fett TN; Scholz G; Bruchhaus J; Burkard M; Kousek R; Ciftci T; Sharps B; Schrenk A; Harrer C; Haering D; Wolkerstorfer B; Zhang X; Lv X; Du A; Li D; Li Y; Quant J; Pearson M; McConnell DB
J Med Chem; 2019 Sep; 62(17):7976-7997. PubMed ID: 31365252
[TBL] [Abstract][Full Text] [Related]
7. Discovery and optimization of piperazine-1-thiourea-based human phosphoglycerate dehydrogenase inhibitors.
Rohde JM; Brimacombe KR; Liu L; Pacold ME; Yasgar A; Cheff DM; Lee TD; Rai G; Baljinnyam B; Li Z; Simeonov A; Hall MD; Shen M; Sabatini DM; Boxer MB
Bioorg Med Chem; 2018 May; 26(8):1727-1739. PubMed ID: 29555419
[TBL] [Abstract][Full Text] [Related]
8. Azacoccone E inhibits cancer cell growth by targeting 3-phosphoglycerate dehydrogenase.
Guo J; Gu X; Zheng M; Zhang Y; Chen L; Li H
Bioorg Chem; 2019 Jun; 87():16-22. PubMed ID: 30852233
[TBL] [Abstract][Full Text] [Related]
9. A retrospective overview of PHGDH and its inhibitors for regulating cancer metabolism.
Zhao JY; Feng KR; Wang F; Zhang JW; Cheng JF; Lin GQ; Gao D; Tian P
Eur J Med Chem; 2021 May; 217():113379. PubMed ID: 33756126
[TBL] [Abstract][Full Text] [Related]
10. α-Ketothioamide Derivatives: A Promising Tool to Interrogate Phosphoglycerate Dehydrogenase (PHGDH).
Ravez S; Corbet C; Spillier Q; Dutu A; Robin AD; Mullarky E; Cantley LC; Feron O; Frédérick R
J Med Chem; 2017 Feb; 60(4):1591-1597. PubMed ID: 28085281
[TBL] [Abstract][Full Text] [Related]
11. The Role of D-3-Phosphoglycerate Dehydrogenase in Cancer.
Zhao X; Fu J; Du J; Xu W
Int J Biol Sci; 2020; 16(9):1495-1506. PubMed ID: 32226297
[TBL] [Abstract][Full Text] [Related]
12. Ixocarpalactone A from dietary tomatillo inhibits pancreatic cancer growth by targeting PHGDH.
Zheng M; Guo J; Xu J; Yang K; Tang R; Gu X; Li H; Chen L
Food Funct; 2019 Jun; 10(6):3386-3395. PubMed ID: 31112178
[TBL] [Abstract][Full Text] [Related]
13. Discovery of PHGDH inhibitors by virtual screening and preliminary structure-activity relationship study.
Zhang FM; Yuan L; Shi XW; Feng KR; Lan X; Huang C; Lin GQ; Tian P; Huang M; Tang S; Gao D
Bioorg Chem; 2022 Apr; 121():105705. PubMed ID: 35235889
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma.
Arlt B; Zasada C; Baum K; Wuenschel J; Mastrobuoni G; Lodrini M; Astrahantseff K; Winkler A; Schulte JH; Finkler S; Forbes M; Hundsdoerfer P; Guergen D; Hoffmann J; Wolf J; Eggert A; Kempa S; Deubzer HE
Int J Cancer; 2021 Mar; 148(5):1219-1232. PubMed ID: 33284994
[TBL] [Abstract][Full Text] [Related]
15. Phosphoglycerate dehydrogenase (PHGDH) inhibitors: a comprehensive review 2015-2020.
Spillier Q; Frédérick R
Expert Opin Ther Pat; 2021 Jul; 31(7):597-608. PubMed ID: 33571419
[No Abstract] [Full Text] [Related]
16. 3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.
Li M; Wu C; Yang Y; Zheng M; Yu S; Wang J; Chen L; Li H
Cell Oncol (Dordr); 2021 Jun; 44(3):541-556. PubMed ID: 33735398
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Novel Drug-like PHGDH Inhibitors to Disrupt Serine Biosynthesis for Cancer Therapy.
Gao D; Tang S; Cen Y; Yuan L; Lan X; Li QH; Lin GQ; Huang M; Tian P
J Med Chem; 2023 Jan; 66(1):285-305. PubMed ID: 36594670
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting PHGDH with NCT-503 reroutes glucose-derived carbons into the TCA cycle, independently of its on-target effect.
Arlt B; Mastrobuoni G; Wuenschel J; Astrahantseff K; Eggert A; Kempa S; Deubzer HE
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1282-1289. PubMed ID: 34192988
[TBL] [Abstract][Full Text] [Related]
19. Identification of Novel Natural Inhibitors to Human 3-Phosphoglycerate Dehydrogenase (PHGDH) for Cancer Treatment.
Sadiqa A; Rasul A; Hassan M; Sultana S; Jabeen F
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144843
[TBL] [Abstract][Full Text] [Related]
20. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer.
Possemato R; Marks KM; Shaul YD; Pacold ME; Kim D; Birsoy K; Sethumadhavan S; Woo HK; Jang HG; Jha AK; Chen WW; Barrett FG; Stransky N; Tsun ZY; Cowley GS; Barretina J; Kalaany NY; Hsu PP; Ottina K; Chan AM; Yuan B; Garraway LA; Root DE; Mino-Kenudson M; Brachtel EF; Driggers EM; Sabatini DM
Nature; 2011 Aug; 476(7360):346-50. PubMed ID: 21760589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
